Roche : Gets FDA Emergency Authorization for Test for Covid-19, Flu

By Matt Grossman

Roche Holding AG on Friday said it has received an emergency-use authorization from the U.S. Food and Drug Administration for a test that can distinguish between Covid-19 and the flu.

The test is for Roche's cobas 6800/8800 system, which can process between 384 and 1,056 tests in an eight-hour period depending on the model used.

Roche said the test will help health-care providers determine which patients are sick with the flu and which are sick with Covid-19--a determination that will grow in importance as flu season approaches.

Write to Matt Grossman at [e-mail]